China-based TandemAI, which uses AI to speed up the design and optimization of drug candidates, raises $25M in seed and pre-Series A funding

chinabased ai preseries
chinabased ai preseries
China-based TandemAI, which uses AI to speed up the design and optimization of drug candidates, raises $25M in seed and pre-Series A funding  —  TandemAI, a Suzhou, and Shangai, China-based provider of a computational platform to accelerate the design and optimization of drug candidates, raised $25m in Seed and pre-Series A financing.
Keep visiting unruggable.net for the latest news and updates.
Daniel Harrison

About the Author: Daniel Harrison

As a blogger and creative writer, I strive to create content that not only informs but also entertains. My passion for SEO allows me to ensure that my writing is seen by as many people as possible. I believe that everyone has a story worth telling, and I am dedicated to helping others share theirs.